TITLE

T-lymphoblastic Leukaemia: A Distinct Variant of Acute Leukaemia

AUTHOR(S)
Catovsky, D.; Goldman, J. M.; Okos, A.; Frisch, B.; Galton, D. A. G.
PUB. DATE
June 1974
SOURCE
British Medical Journal;6/22/1974, Vol. 2 Issue 5920, p643
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64110812

 

Related Articles

  • 3. The leukaemisa.  // GP: General Practitioner;2/3/2003, p88 

    Focuses on types of leukaemia. Description of childhood leukaemia; Symptoms of acute lymphoblastic leukaemia; Treatment of the disease.

  • Cladribin.  // Reactions Weekly;10/13/2012, Issue 1423, p17 

    The article describes the case of a 57-year-old White man who developed secondary T-lymphoblastic leukaemia during treatment with cladribine for hairy cell leukaemia.

  • Loci other than 21q22.12 (RUNX1) and 16q21-23.2 cause familial AML. Sellick, G. S; Pritchard-Jones, K; Shepherd, V; Swansbury, J; Catovsky, D; Houlston, R. S // Leukemia (08876924);Mar2005, Vol. 19 Issue 3, p465 

    Presents a letter to the editor related to acute myeloblastic leukaemia.

  • Multiple relapses and extramedullary localization with scalp and breast involvement in a case of acute promyelocytic leukaemia. Ammatuna, E; Borza, P. A; Iori, A. P; Petti, M. C; Pescarmona, E; Diverio, D; Lo-Coco, F // Leukemia (08876924);Mar2005, Vol. 19 Issue 3, p479 

    Presents a letter to the editor related to acute promyelocytic leukaemia.

  • Long-term seventh molecular remission in acute promyelocytic leukaemia. Cicconi, Laura; Romano, Atelda; Ramadan, Safaa; Divona, Mariadomenica; Petti, Maria; Lo-Coco, Francesco // Annals of Hematology;Nov2011, Vol. 90 Issue 11, p1369 

    A letter to the editor is presented about acute promyelocytic leukaemia.

  • ACUTE MYELOID LEUKAEMIA.  // Rugby League Week;5/18/2011, p14 

    The article offers information on acute myeloid leukaemia (AML).

  • Smoking and the risk of acute myeloid leukaemia in cytogenetic subgroups. Moorman, A.V.; Roman, E.; Cartwright, R.A.; Morgan, G.J. // British Journal of Cancer;1/7/2002, Vol. 86 Issue 1, p60 

    Cytogenetically-defined subgroups of acute myeloid leukaemia have distinct biologies, clinical features and outcomes. Evidence from therapy-related leukaemia suggests that chromosomal abnormalities are also markers of exposure. Our results suggest that the smoking-associated risk for acute...

  • A complex variant t(3;15) (q26;q13) representing cryptic/masked acute promyelocytic leukaemia with a novel breakpoint of chromosome 15--a case report. Appachu, Sandhya; Obulareddy, Chintaparthi; Sirsath, Nagesh T.; Lakshmaiah, Kuntejowdahalli C.; Kumari, Prasanna // Ecancermedicalscience;2013, Vol. 7 Issue 334-360, p1 

    Acute promyelocytic leukaemia (APML) is a biologically and clinically distinct variant of AML, currently classified as acute myeloid leukaemia with recurrent cytogenetic anomalies t(15;17) (q22;q21), promyelocytic leukaemia-retinoic acid receptor alpha, diagnosis regardless of blast count in the...

  • Unusual Presentation of Acute Leukaemia: A Tripod of Cases. KISHORE, MANJARI; KUMAR, VIJAY; MARWAH, SADHNA; NIGAM, ABHAY S. // Journal of Clinical & Diagnostic Research;Oct2016, Vol. 10 Issue 10, p4 

    Acute Leukaemia is one of the common haematological malignancies encountered with varied clinical and haematological presentation. In acute leukaemia, complications like bleeding and infection cause significant morbidity and mortality, thus overshadowing the thromboembolic events. Among the...

  • Antineoplastics/immunosuppressants.  // Reactions Weekly;11/10/2007, Issue 1177, p7 

    The article describes a case of severe systemic candidiasis induced by treatment with dexamethasone, vincristine, daunorubicin, pegaspathase, cyclophosphamide, cytarabine, mercaptopurine, methotrexate, etoposide and other anti-inflammatory agents and immunosuppressants. The drugs were...

Share

Read the Article

Other Topics